Marsden J

Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

4 papers · ORCID

ArticleDMT

Psychological change processes in alcohol use disorder: A qualitative study of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) with cognitive behavioural therapy.

Seynaeve M, Dunbar F, Ermakova AO +4

Europe PMC2026
ArticleDMT

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trial.

Marsden J, Kelleher M, Dunbar F +8

Europe PMC2025
ArticlePsilocybin

Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.

Piper T, Small F, Brown S +5

Europe PMC2025
ArticlePsilocybin

Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?

Andrews CM, Hall W, Humphreys K +1

Europe PMC2025